Eisai Pharma to set up Global Capability Centre in Visakhapatnam

Eisai Pharma, a global leader in human healthcare innovation, has announced plans to establish a state-of-the-art Global Capability Centre (GCC) in Visakhapatnam, Andhra Pradesh.

MTaI Flags MMC Move Letting Homoeopaths Use Modern Medicines

The Medical Technology Association of India (MTaI) has strong objections to a recent notification issued by the Maharashtra Medical Council (MMC) that allows homoeopathy practitioners to administer allopathic drugs

Indian Pharma Boosts NDDS Research for Precision Drug Delivery

India's pharmaceutical sector is undergoing a significant transformation, both in the discovery of new medicines and advancements in drug delivery.

Trump's 200% Tariff Threat on Drug Imports Worries India

President Donald Trump on Tuesday announced a possible 200% tariff on imported pharmaceuticals. Speaking at a White House cabinet meeting, he said the goal is to push drug companies to make their medicines in the U.S. instead of overse...

Doctors Threaten Strike Over Maharashtra's Allopathy Order for Homeopaths

In a significant flashpoint for the medical community, allopathic doctors in Maharashtra have threatened to go on strike on July 11 over the state's plan to allow homeopathic practitioners to register with the Maharashtra Medical Council (MMC) by...

India's Pharmacovigilance Momentum Takes Center Stage

The 4th Edition Drug Safety Symposium 2025 – India Chapter, hosted by Eminence Business Media, once again proved to be a cornerstone event in the evolving landscape of pharmacovigilance in India. With the theme “Beyond Compliance – Creating a Future

Sun Pharma Ramps Up USFDA Compliance Efforts at Key Plants

Sun Pharmaceutical Industries is working toward a complete regulatory resolution for three of its manufacturing facilities that are being reviewed by the US Food and Drug Administration (USFDA). Sun Pharmaceutical has completed way of corrective...

Telangana Pharma Leaders Push for Safety as Pillar of Growth

At the CII Telangana, "Pillars of Protection" conference on pharmaceutical manufacturing safety in Hyderabad, government officials and industry professionals highlighted that safety needs to be embedded in every aspect of their operations...

VarmX Secures FDA Approval for Phase 3 Trial of VMX-C001

VarmX, a Dutch-based biotech company headquartered in Leiden, has been given clearance by the U. S. FDA to carry out a pivotal Phase 3 clinical trial on its lead candidate, the VMX-C001. The novel bypass agent can be used to reactivate coagulati...

Karnataka to Mandate Yearly Heart Checks Amid Rising Cardiac Deaths

In response to increasing rates of sudden cardiac death caused by heart attacks, the Karnataka government will soon make it mandatory for every employee working in the corporate and private sectors to get a health checkup annually

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.